halozyme.com (HALO): Earnings growth forecast for next year

Corporate emblem and logo of Halozyme Inc. (HALO)

Halozyme Therapeutics (HALO) is transforming oncology therapy by converting intravenous drugs into subcutaneous injection formats. Current revenue is based on royalties from the use of the ENHANZE system by corporate behemoths. Analyst valuations based on n+1 net profit dynamics demonstrate the high margins of the asset-light model, with the current figure standing at 19.60, confirming the company's stable cash flow.

HALO: Halozyme Inc. Earnings growth forecast for next year 07/04/2022 - 11/18/2026

Metric breakdowns and analytics for Halozyme Inc. (HALO)

- share price and consensus valuation forecast:
Summary company analytics:Halozyme Therapeutics, Inc.
Core merchandise of Halozyme Therapeutics, Inc.

This indicator measures the analysts' consensus forecast for the change in earnings per share for the coming year. This forward-looking assessment of net income dynamics reflects market expectations regarding the future profitability of the business. The metric is sensitive to revisions in earnings models, where inflated figures often foreshadow a price correction. For Halozyme (HALO), rising values confirm a steady stream of royalties from pharma behemoths utilizing their unique subcutaneous delivery technology.

Competitors of Halozyme Therapeutics

ONC (BeiGene Ltd) - Earnings growth forecast for next year|Expected net earnings per share growth next year revmed.com RVMD|Earnings growth forecast for next year AAPG|Expected earnings per share growth for next year CG Oncology CGON|Net earnings per share growth forecast for next year UroGen URGN|Consensus forecast of earnings per share growth for next year Bicara Bio (BCAX)|PSNL - Net earnings per share growth forecast for next year|ERAS - Earnings growth forecast for next year|DCTH: Earnings growth forecast for next year|Y-mAbs Therapeutics, Inc. (YMAB) - Earnings growth forecast for next year|Expected earnings per share growth for next year AURA|Expected net earnings per share growth next year candeltx.com CADL|Earnings growth forecast for next year ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Expected earnings per share trend next year|Earnings growth forecast for next year ACTU (Actuate Therapeutics Inc)|Expected earnings per share trend next year CTOR|tuhurabio.com - Earnings growth forecast for next year|Expected earnings per share trend next year TARA (Protara Therapeutics)|Fate Therapeutics, Inc. (FATE) - Net earnings per share growth forecast for next year|WHWK - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year tscan.com|CSBR: Expected earnings per share trend next year|Net earnings per share growth forecast for next year XBiotech USA (XBIT)|CVM: Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year ostherapies.com OSTX|Projected earnings per share increase next year RADX (Radiopharm Theranostics Limited)|Artiva - Earnings growth forecast for next year|ANL: Net earnings per share growth forecast for next year|VERU: Earnings growth forecast for next year|Net earnings per share change forecast for next year TPST (Tempest Tx)|XLO (Xilio Therapeutics) - Earnings growth forecast for next year|Expected net earnings per share growth next year renovarobio.com RENB|Net earnings per share growth forecast for next year muraloncology.com (MURA)|Projected earnings per share increase next year KAPA|Earnings growth forecast for next year OKUR (onkuretherapeutics.com)|Projected earnings per share increase next year GDTC (CytoMed)|Curis - Earnings growth forecast for next year|APLM: Net earnings per share growth forecast for next year|Tharimmune (THAR) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Advanced Biomed Inc.|GNPX (Genprex Inc) - Earnings growth forecast for next year|Calidi Biotherapeutics (CLDI) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year SBFM|Net earnings per share growth forecast for next year XBIO (Xenetic Biosciences, Inc.)|Earnings growth forecast for next year SLRX (salariuspharma.com)|PPBT - Expected earnings per share growth for next year|AONC - Net earnings per share growth forecast for next year|Expected earnings per share trend next year BGNE (BeOne Medicines)|CKPT: Earnings growth forecast for next year|Elevation Oncology Inc. (ELEV) - Earnings growth forecast for next year|ICAD (iCAD) - Earnings growth forecast for next year|Earnings growth forecast for next year ikenaoncology.com|Earnings growth forecast for next year NTBL|Earnings growth forecast for next year Viracta Therapeutics Inc. (VIRX)|Net earnings per share growth forecast for next year MorphoSys Inc MOR|Expected earnings per share trend next year NAYA|AAPGV: Expected earnings per share growth for next year